Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

AFX News-Archiv vom 10.09.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
10.09.23Vietnam Airlines To Sign Multi-billion-dollar Deal To Buy 50 Boeing 737 MAX Aircraft712SANTA CLARA (dpa-AFX) - Boeing and Vietnam Airlines will sign a multi-billion-dollar proposal acceptance to purchase 50 Boeing 737 MAX aircraft that will benefit both countries by supporting...
► Artikel lesen
10.09.23Alibaba's Cloud Division Chief Daniel Zhang Reportedly To Step Down687BEIJING (dpa-AFX) - Alibaba Group Holding Ltd.'s (BABA) former chief executive officer Daniel Zhang has decided to step down just months after agreeing to lead its cloud division, according...
► Artikel lesen
10.09.23Amgen Reports Positive Data From Phase 1 Study Of Lumakras Combination In Non-small Cell Lung Cancer837THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) announced positive data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating Lumakras (sotorasib) with carboplatin and pemetrexed...
► Artikel lesen
10.09.23Gilead: Phase 2 Study Of Trodelvy Combination Shows Promising Clinical Activity In Lung Cancer1.052FOSTER CITY (dpa-AFX) - Gilead Sciences Inc.'s (GILD) phase 2 EVOKE-02 Study of Trodelvy in combination with Merck & Co Inc.'s (MRK) Keytruda demonstrated promising clinical activity in first-line...
► Artikel lesen
10.09.23Gilead: Phase 2 Study Of Trodelvy Combination Shows Promising Clinical Activity In Lung Cancer1.197FOSTER CITY (dpa-AFX) - Gilead Sciences Inc.'s (GILD) phase 2 EVOKE-02 Study of Trodelvy in combination with Merck & Co Inc.'s (MRK) Keytruda demonstrated promising clinical activity in first-line...
► Artikel lesen